Roth Capital analyst Suji Desilva lowered the firm’s price target on ACM Research (ACMR) to $40 from $50 and keeps a Buy rating on the shares. The company reported a Q3 recovery on a continued demand ramp, the analyst tells investors in a research note. Roth expects ACM’s near-term margin headwinds to be temporary but reduced estimates post the Q3 report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACMR:
- ACM Research narrows FY25 revenue view to $875M-$925M from $850M-$950M
- ACM Research reports Q3 adjusted EPS 36c, consensus 53c
- ACM Research reports preliminary Q3 revenue $264M-$267M, consensus $251.72M
- ACM Research price target raised to $50 from $40 at Roth Capital
- ACM Research Reports Significant Backlog Increase